Modelling and simulation in drug absorption processes

References

• Agoram B, Woltasz WS, Bolger MB. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Advanced Drug Delivery Reviews 2001; 50: S41–S67
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research 1995; 12: 413–420
   PubMed Web of Science ®Google Scholar
• Bergstrom C, Strafford M, Lazorova A, Avdeef A, Luthman K, Artursson P. Absorption classification of oral drugs based on molecular surface properties. Journal of Medicinal Chemistry 2003; 46: 558–570
   PubMed Web of Science ®Google Scholar
• Brunner E. Reaktionsgeschwindigkeit in heterogenen Systemen. Zeitschrift für Physikalische Chemie 1904; 43: 56–102
   Google Scholar
• Digenis GA, Sandefer EP, Parr AF, Beihn R, McClain C, Scheinthal BM, Ghebre-Sellassie I, Iyer U, Nesbitt RU, Randinitis E. Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy. Journal of Clinical Pharmacology 1990; 30: 621–631
   PubMed Web of Science ®Google Scholar
• Dokoumetzidis A, Papadopoulou V, Macheras P. Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function. Pharmaceutical Research 2006; 23: 256–261
   PubMed Web of Science ®Google Scholar
• Dressman JB, Fleisher D. Mixing-tank model for predicting dissolution rate control or oral absorption. Journal of Pharmaceutical Sciences 1986; 75: 109–116
   PubMed Web of Science ®Google Scholar
• Dressman JB, Amidon GL, Fleisher D. Absorption potential: Estimating the fraction absorbed for orally administered compounds. Journal of Pharmaceutical Sciences 1985; 74: 588–589
   PubMed Web of Science ®Google Scholar
• FDA Guidance for Industry: SUPAC-IR: Immediate Release Solid Oral Dosage Forms—CDER 10/1997
   Google Scholar
• FDA Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation and Application of IVIVC—CDER 09/1997(a)
   Google Scholar
• FDA Guidance for Industry: SUPAC-MR: Modified Release Solid Oral Dosage Forms–CDER 09/1997(b)
   Google Scholar
• FDA Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products—General considerations—CDER 10/2000
   Google Scholar
• FDA Guidance for Industry, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System – CDER 08/2000
   Google Scholar
• Grass GM. Simulation models to predict oral drug absorption from in vitro data. Advanced Drug Delivery Reviews 1997; 23: 199–219
   Web of Science ®Google Scholar
• Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. Journal of Pharmaceutical Sciences 1961; 50: 874–875
   PubMed Web of Science ®Google Scholar
• Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Industrial & Engineering Chemistry 1931; 23: 923–931
   Google Scholar
• Kalampokis A, Argyrakis P, Macheras P. Heterogeneous tube model for the study of small intestinal transit flow. Pharmaceutical Research 1999a; 16: 87–91
   PubMed Web of Science ®Google Scholar
• Kalampokis A, Argyrakis P, Macheras P. A heterogeneous tube model of intestinal drug absorption based on probabilistic concepts. Pharmaceutical Research 1999b; 16: 1764–1769
   PubMed Web of Science ®Google Scholar
• Kelly K, O’Mahony B, Lindsay B, Jones T, Grattan T, Stevens H, Wilson C. Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy. Pharmaceutical Research 2003; 20: 1668–1673
   PubMed Web of Science ®Google Scholar
• Kopelman R. Fractal reaction-kinetics. Science 1988; 241: 1620–1626
   PubMed Web of Science ®Google Scholar
• Kortejarvi H, Urti A, Yliperttula M. Pharmacokinetic simulation of biowaiver criteria: The effects of gastric emptying, dissolution, absorption and elimination rates. European Journal of Pharmaceutical Sciences 2007; 30: 155–166
   PubMed Web of Science ®Google Scholar
• Kosmidis NA, Argyrakis P, Macheras P. Fractal kinetics in drug release from finite fractal matrices. Journal of Chemical Physics 2003a; 119: 6373–6377
   Web of Science ®Google Scholar
• Kosmidis K, Argyrakis P, Macheras P. A reappraisal of drug release laws using Monte Carlo simulations: The prevalence of the Weibull function. Pharmaceutical Research 2003b; 20: 988–995
   PubMed Web of Science ®Google Scholar
• Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. Journal of Pharmacy and Pharmacology 1972; 24: 979–981
   PubMed Web of Science ®Google Scholar
• Levich VG. Physicochemical hydrodynamics. Prentice-Hall, Englewood Cliffs 1962
   Google Scholar
• Linnankofski J, Makela J, Ranta VP, Urti A, Yliperttula M. Computational prediction of oral drug absorption based on absorption rate constants in humans. Journal of Medicinal Chemistry 2006; 49: 3674–3681
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 1997; 23: 3–25
   Web of Science ®Google Scholar
• Macheras P, Symillides M. Towards a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. Biopharmaceutics and Drug Disposition 1989; 10: 43–53
   PubMed Web of Science ®Google Scholar
• Macheras P, Argyrakis P. Gastrointestinal drug absorption: Is it time to consider heterogeneity as well as homogeneity?. Pharmaceutical Research 1997; 14: 842–847
   PubMed Web of Science ®Google Scholar
• Macheras P, Dokoumetzidis A. On the heterogeneity of drug dissolution and release. Pharmaceutical Research 2000; 17: 108–112
   PubMed Web of Science ®Google Scholar
• Macheras P, Iliadis A. Modelling in biopharmaceutics, pharmacokinetics and pharmacodynamics: homogeneous and heterogeneous approaches. Springer, New York 2006
   Google Scholar
• Nernst W. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen. Zeitschrift für Physikalische Chemie 1904; 47: 52–55
   Google Scholar
• Ni PF, Ho NF.H, Fox JL, Leuenberger H, Higuchi WI. Theoretical-model studies of intestinal drug absorption. 5. Non-steady-state fluid-flow and absorption. International Journal of Pharmaceutics 1980; 5: 33–47
   Web of Science ®Google Scholar
• Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. Journal of the American Chemical Society 1897; 19: 930–934
   Google Scholar
• Oh DM, Curl RL, Amidon GL. Estimating the fraction absorbed from suspensions of poorly soluble compounds in humans: A mathematical model. Pharmaceutical Research 1993; 10: 264–270
   PubMed Web of Science ®Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceutica Acta Helvetiae 1985; 60: 110–111
   PubMedGoogle Scholar
• Rinaki E, Dokoumetzidis A, Macheras P. The mean dissolution time depends on dose/solubility ratio. Pharmaceutical Research 2003a; 20: 406–408
   PubMed Web of Science ®Google Scholar
• Rinaki E, Valsami G, Macheras P. Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio. Pharmaceutical Research 2003b; 20: 1917–1925
   PubMed Web of Science ®Google Scholar
• Rinaki E, Dokoumetzidis A, Valsami G, Macheras P. Identification of biowaivers among class II drugs: Theoretical justification and practical examples. Pharmaceutical Research 2004; 21: 1567–1572
   PubMed Web of Science ®Google Scholar
• Sawamoto T, Haruta S, Kurosaki Y, Higaki K, Kimura T. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability. Journal of Pharmacy Pharmacology 1997; 49: 450–457
   PubMed Web of Science ®Google Scholar
• Sinko PJ, Leesman GD, Amidon GL. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharmaceutical Research 1991; 8: 979–988
   PubMed Web of Science ®Google Scholar
• Stenberg P, Bergstrom C, Luthman K, Artursson P. Theoretical predictions of drug absorption in drug discovery and development. Clinical Pharmacokinetics 2002; 41: 877–899
   PubMed Web of Science ®Google Scholar
• Sun D, Lennernas H, Welage LS, Barnetti JL, Landowski CP, Foster D, Fleisher D, Lee KD, Amidon GL. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharmaceutical Research 2002; 19: 1400–1416
   PubMed Web of Science ®Google Scholar
• Turner J, Maddalena D, Agatonovic-Kustrin S. Bioavailability prediction based on molecular structure for a diverse series of drugs. Pharmaceutical Research 2004; 21: 68–82
   PubMed Web of Science ®Google Scholar
• USP. The Official Compendia of Standards. U.S. Pharmacopoeia, Rockville, MD, 208/2 2006, 29–NF 24
   Google Scholar
• Wang JZ, Flanagan DR. General solution for diffusion controlled dissolution of spherical particles. 1. Theory. Journal of Pharmaceutical Sciences 1999; 88: 731–738
   PubMed Web of Science ®Google Scholar
• Weitschies W, Wedemeyer J, Stehr R, Trahms L. Magnetic markers as a noninvasive tool to monitor gastrointestinal transit. IEEE Transactions on Biomedical Engineering 1994; 41: 192–195
   PubMed Web of Science ®Google Scholar
• Willmann S, Schmitt W, Keldenich J, Dressmann JB. A physiologic model for simulating gastrointestinal flow and drug absorption in rats. Pharmaceutical Research 2003; 20: 1766–1771
   PubMed Web of Science ®Google Scholar
• Willmann S, Schmitt W, Keldenich J, Lippert J, Dressmann JB. A physiological model for the estimation of the fraction dose absorbed in humans. Journal of Medicinal Chemistry 2004; 47: 4022–4031
   PubMed Web of Science ®Google Scholar
• Wu CY, Benet LZ. Predicting drug disposition via application of BCS: Transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharmaceutical Research 2005; 22: 11–23
   PubMed Web of Science ®Google Scholar
• Yalkowsky SH, Johnson JL, Sanghvi T, Machatha SG. A ‘rule of unity’ for human intestinal absorption. Pharmaceutical Research 2006; 23: 2475–2481
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon GL. A compartmental absorption and transit model for estimating oral drug absorption. International Journal of Pharmaceutics 1999; 186: 119–125
   PubMed Web of Science ®Google Scholar
• Yu LX, Crison JR, Amidon GL. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. International Journal of Pharmaceutics 1996; 140: 111–118
   Web of Science ®Google Scholar
• Zhao Y, Le J, Abraham M, Hersey A, Eddershaw P, Luscombe C, Butina D, Beck G, Sherborne B, Cooper I, et al. Evaluation of human intestinal absorption data and subsequent derivation of quantitative structure-activity relationship (QSAR) with the Abraham descriptors. Journal of Pharmaceutical Sciences 2001; 90: 749–784
   PubMed Web of Science ®Google Scholar
• Zhao Y, Abraham M, Le J, Hersey A, Lunscombe C, Beck G, Sherborne B, Cooper I. Rate limited steps of human oral absorption and QSAR studies. Pharmaceutical Research 2002; 19: 1446–1457
   PubMed Web of Science ®Google Scholar